Drug Trial News

RSS

Brain regions that regulate different aspects of behavior may affect an adolescent's response to peer influence

Brain regions that regulate different aspects of behavior are more interconnected in children with high resistance to peer influence than those with low resistance, according to a new study published in the July 25 issue of The Journal of Neuroscience .

27 Jul 2007

Treating bronchiolitis with steroids doesn't work

For infants with a common and potentially serious viral lower respiratory infection called bronchiolitis, a widely used steroid treatment is not effective.

27 Jul 2007

Sexual problems of long-term cancer survivors merit more attention

The first study to look at sexual function in very long-term female survivors of genital-tract cancer found that these women were pleased with the quality of their cancer care but less satisfied with the emotional support and information they received about dealing with the effects of the disease and treatment on sexuality.

27 Jul 2007

Severe trauma affects kids' brain function

The first study to examine brain activity patterns in severely traumatized children showed their brains function differently than those of healthy children, say researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital.

27 Jul 2007

Proactive chlamydia screening does not represent good value for money

Proactive chlamydia screening for young adults is an expensive intervention that probably does not represent good value for money, concludes a study published on bmj.com today.

27 Jul 2007

Prescribing antibiotics to children remains common practice

Regular prescribing of antibiotics to children in the community is sufficient to sustain a high level of antibiotic resistance in the population, warn experts in a study published on bmj.com.

27 Jul 2007

Malt liquor linked to marijuana use

The cheap, high-alcohol beverage often marketed to teens -- may put young adults at increased risk for alcohol problems and use of illicit drugs, particularly marijuana, according to a new study of malt liquor drinkers and marijuana use by scientists at the University at Buffalo's Research Institute on Addictions (RIA).

27 Jul 2007

FDA statement on gene therapy trial

On July 24, 2007 the U.S. Food and Drug Administration (FDA) was informed by Targeted Genetics Corporation of Seattle about the death of a patient who received an investigational gene therapy product in a clinical trial for the treatment of active inflammatory arthritis.

27 Jul 2007

Thiazolinediones increase risk of heart failure

A class of drugs commonly used to treat type 2 diabetes may double the risk of heart failure, according to a new analysis by researchers at Wake Forest University School of Medicine and colleagues.

27 Jul 2007

Antipsychotic drugs for dementia

Antipsychotic drugs are approved mainly for treating schizophrenia and bipolar disorder, but they are also used for many other purposes.

27 Jul 2007

Cannabis use and risk of psychotic or affective mental health outcomes

Further evidence that using cannabis could increase the risk of developing a psychotic illness such as schizophrenia, later in life, is revealed today in a study published in The Lancet.

27 Jul 2007

Study links brain anatomy to the ability to learn a second language in adulthood

Think you haven't got the aptitude to learn a foreign language, New research led by Northwestern University neuroscientists suggests that the problem, quite literally, could be in your head.

26 Jul 2007

GPs antibiotic prescribing practices are still contributing to resistance

GPs are still prescribing antibiotics for up to 80% of cases of sore throat, otitis media, upper respiratory tract infections, and sinusitis, despite the fact that official guidance warns against this practice, according to an analysis of the world's largest primary care database of consultations and prescriptions, published this week in a supplement to the Journal of Antimicrobial Chemotherapy.

26 Jul 2007

Concerns noted on study of soft drinks and metabolic syndrome

A recent observational study reported in the journal Circulation ("Soft Drink Consumption and Risk of Developing Cardiometabolic Risk Factors and the Metabolic Syndrome in Middle-Aged Adults") needs to be considered in the proper scientific context, especially in relation to other previously published research that has reached the opposite conclusion.

26 Jul 2007

Smoking may not help relieve real anxiety

Many smokers excuse their habit by claiming that smoking relieves their feelings of stress.

26 Jul 2007

Combination of blood pressure-lowering drugs stops loss of kidney function in rare genetic disease

A combination of two types of blood pressure-lowering drugs, an angiotensin-converting enzyme inhibitor (ACEI) plus an angiotensin-receptor blocker (ARB), added to enzyme replacement therapy (ERT) with agalsidase-beta (Fabrazyme, Genzyme Corporation, Cambridge, MA) is the first treatment shown to stop progressive loss of kidney function in patients with severe kidney involvement due to the rare genetic disorder Fabry disease, reports a study in the September Journal of the American Society of Nephrology.

26 Jul 2007

WHO announces China and India join clinical trial registry platform

The World Health Organisation (WHO) has announced the expansion of its clinical trial registry platform to include trial registers from China and India.

26 Jul 2007

Dexamethasone steroid treatment shows no benefit for kids with bronchiolitis

DMC Children's Hospital of Michigan has found that a common steroid treatment often prescribed for kids with bronchiolitis has no impact on improving their symptoms or in reducing hospitalization.

26 Jul 2007

Study says you're not as generous as you think

A new study out of Carnegie Mellon University reveals that people who regard themselves as humanitarians are even more likely than others to base donations to the poor on whether they believe poverty is a result of bad luck or bad choices.

26 Jul 2007

Biologic agents valuable treatment option for patients with inflammatory bowel disease

The use of biologic agents for the treatment of inflammatory bowel disease (IBD) may benefit patients, but doctors need to consider the potential associated side effects in determining treatment course, according to a consensus paper published in this month's issue of Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

26 Jul 2007